Atlas Trials

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

Clinical trial NCT01526733 · COMPLETED

Trial details

NCT number
NCT01526733
Sponsor
Halozyme Therapeutics
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2011-12-01
Primary completion
2012-08-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.